Related Experiment Videos
The effect of IFNgamma on the hepatocyte: cell cycle and apoptosis
B J Tura1, K E Bunyan, D J Harrison
1Cell Injury and Apoptosis Group, (Department of Pathology), MRC Centre for Inflammation Research, University of Edinburgh Medical School, Edinburgh, UK.
Abstract:
The inflammatory cytokine interferon gamma (IFNgamma) can cause cell cycle arrest and apoptosis in the hepatocyte. Primarily these processes are protective but in chronic liver disease oncogenic mutations may prosper. IFNgamma signalling is discussed showing how p53 is induced to cause cell cycle arrest. While caspases are are known to be responsible for IFNgamma induced apoptosis, how they are activated is unclear. Potential mechanisms are reviewed.
Insights
Interferon gamma (IFNgamma) triggers protective cell death in liver cells, but can paradoxically promote cancer in chronic liver disease. This review explores IFNgamma
Area of Science:
- Hepatology
- Immunology
- Molecular Biology
Background:
- Hepatocytes are susceptible to cell cycle arrest and apoptosis induced by the inflammatory cytokine interferon gamma (IFNgamma).
- While typically protective, these IFNgamma-mediated processes may inadvertently support oncogenic mutations in chronic liver disease.
- Understanding IFNgamma signaling is crucial for comprehending liver disease progression.
Purpose of the Study:
- To review the mechanisms of interferon gamma (IFNgamma) signaling in hepatocytes.
- To elucidate the induction of p53 and subsequent cell cycle arrest by IFNgamma.
- To explore the unclear activation pathways of caspases in IFNgamma-induced apoptosis.
Main Methods:
- Literature review of IFNgamma signaling pathways.
- Analysis of molecular mechanisms underlying p53 induction.
- Investigation of caspase activation cascades in response to IFNgamma.
Main Results:
- IFNgamma signaling induces the tumor suppressor protein p53, leading to cell cycle arrest in hepatocytes.
- Caspases are implicated in IFNgamma-induced apoptosis, but their precise activation mechanisms remain to be fully elucidated.
- Potential pathways for caspase activation in this context are reviewed.
Conclusions:
- IFNgamma plays a dual role in liver health, offering protection but potentially fostering oncogenesis in chronic disease.
- Further research into caspase activation is needed to fully understand IFNgamma-mediated hepatocyte apoptosis.
- Clarifying these pathways could inform therapeutic strategies for chronic liver disease.